Seeking Alpha

R. Scott Raynovich's  Instablog

R. Scott Raynovich
Send Message
R. Scott Raynovich is an internationally recognized expert in technology, telecom, and investment markets. He has been quoted in publications including Reuters, Dow Jones, Barron's, and the San Jose Mercury News. He has also been interviewed on CNN and National Public Radio. From 2000 to 2008,... More
My company:
The Rayno Report
My blog:
The Rayno Report
  • Biotech Getting Creamed -- What's Up? 0 comments
    Oct 21, 2009 12:09 PM | about stocks: AMGN, BBI, OSIP, BIIB, CEPH, GILD, ALXN, VRTX, ACOR
    Our partners at Raygent Associates (www.raygent.com) have pointed out that Biotech has been getting creamed in the last two sessions:


    Yesterday, Biotech stocks were in a broad retreat for reasons that are not yet apparent. The Nasdaq and S&P were only down a modest 0.6%, but large cap biotechs that were hard hit include Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB),and Vertex (NASDAQ:VRTX) as well as the major ETF’s.

    The Raygent Broad Biotech index of 35 mid cap biotechs was down 3.3% with some stocks down 4-5%. With the exception of a few tiny gains every stock in the index was in the red. The Rayno Life Science portfolio was down 3% and is now only up 9% YTD after being up 15%+. News can account for drop on specific stocks like AMGN which was buffeted by an FDA request for more information on its anticipated blockbuster denosumab. Amgen reports earnings on Wednesday.

    Large cap pharma stocks have been in a rally mode lately and were stable today with ABT,GSK and PFE down less than 1%.

    One question I have: How big a factor is the Galleon Group in the Biotech slaughter? Although Galleon is only a marginal biotech player, they do have some large holdings. The hedge fund, whose founder Raj Rajaratnam has been charged with insider trading, has announced that it will be winding down its funds, which of course could bring further liquidation of its larger holdings.

    As of the most recent available filing data -- June 30 -- Galleon held large positions in these biotech stocks: OSIP, BIIB, CEPH, GILD, ALXN, VRTX, ACOR,
    ILMN, QDEL, DNDN, BMRN, ISPH.

    Stocks: AMGN, BBI, OSIP, BIIB, CEPH, GILD, ALXN, VRTX, ACOR
Back To R. Scott Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • Gold stocks like NEM and GOLD have barely pulled back on vicious gold correction. Telegraphing a quick recovery in gold, methinks.
    Jul 30, 2010
  • Looking at a new tech stock BCSI.
    Dec 11, 2009
  • Wow.. monster rally in the dollar today. indicative of the end of the move?
    Dec 11, 2009
More »

Latest Comments


Most Commented
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.